Herbalife CFO John DeSimone on the company’s 2Q earnings miss and Bill Ackman ’s claims.
FBN’s Liz MacDonald on Bill Ackman calling for a shareholder vote on the Valeant-Allergan merger.
Kleinberg Kaplan partner Chris Davis on Bill Ackman ’s call for a shareholder vote on the Valeant-Allergan merger.
Under what circumstances would Warren Buffett become the ‘ Bill Ackman ’ or ‘Carl Icahn’ of Coca Cola and/or other major companies?
FBN’s Charlie Gasparino on Bill Ackman ’s movie.
Skybridge Capital’s Troy Gayeski weighs in on activist investors like Carl Icahn and Bill Ackman .
Charlie Gasparino, James Freeman and Ken Mahoney on Bill Ackman ’s deal with an ex-Herbalife exec.
Trading Advantage’s Larry Levin, Capital Wave Forecast editor Shah Gilani, FBN’s Lauren Simonetti, Nicole Petallides and Liz MacDonald on Valeant and Bill Ackman ’s partnership.
Hedge fund manager Bill Ackman agreed to pay an Herbalife whistleblower as much as $3.6 million if the executive lost his job with the nutritional supplements maker,...
AlphaClone CEO Maz Jadallah and FBN’s Charlie Gasparino on activist Bill Ackman ’s decision to team up with Valeant for a bid for Allergan.
Billionaire activist investor William Ackman said today that the way he accumulated his stake in Botox-maker Allergan (NYSE:AGN) was above the board and did not viol...
FBN’s Charlie Gasparino, Barron’s Jack Hough and NYU professor Mark Brennan on Bill Ackman ’s bid for Allergan.
Valeant Pharmaceuticals Inc won't pay whatever it takes to acquire rival Allergan Inc, and it will not turn its bid into an all-cash deal, Valeant Chief Executive Mi...
Columbia Law School Professor John Coffee on Bill Ackman ’s accusations against Herbalife.
Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, Apple and Microsoft earnings, Herbalife’s stock surge and billionaire investor Bill Ackman ’s accusations against the company.
Herbalife CFO John DeSimone reacts to Pershing Square Capital Management CEO Bill Ackman ’s latest attacks.
Maureen Farrell of The Wall Street Journal on Pershing Square Capital Management CEO Bill Ackman ’s comments on Herbalife.
FBN contributor Bob Rice delves into Pershing Square Capital Management CEO Bill Ackman ’s disclosure of details into Herbalife’s investigation.
Wall Street Journal reporter David Benoit and FOX Business contributor Bob Rice on Allergan looking to potential acquisitions to fend off activist investor Bill Ackman .
Filmmaker Ted Braun on making a documentary about Herbalife’s battle with Bill Ackman .